Stocks to buy: From Cipla to Fortis, ICICI Securities bets on these 8 firms in healthcare space

Indian healthcare space has weathered storms to emerge stronger, said ICICI Securities. It has listed top bets in different areas of this sector: in US generics space - Cipla, Sun Pharma &amp; Zydus, whereas in India business - Ajanta &amp; Abbott.&nbsp;

Pharma firms' third quarter numbers remain in line with expectations; Lupin, Divi's Labs see downgrades

Brokerage firm Motilal Oswal Financial Services observed the December quarter earnings of the pharma companies under its coverage were in line with expectations.

Jefferies says big pharma firms to get bigger; lists Sun Pharma and Syngene as top picks, downgrades Biocon, Cipla

Jefferies expects big companies and big brands to become bigger as consolidation gathers pace in the pharma sector.

Sun Pharma vs Cipla: Which is a better pharma bet for long term?

Even as the Nifty Pharma index gave negative returns in the last 1 year, down over 8 percent, both stocks gave double-digit positive returns during the period.

IT, pharma still offer some value, says Kenneth Andrade of Old Bridge Capital

Andrade said the banking sector is going through a valuation cycle as they are available at a significantly cheaper valuation.

This is the only pharma stock with double-digit growth in 2022 so far

One must note that the pharma index performed tremendously when the COVID pandemic hit. The pharma index jumped 70 percent between March and December 2020.

Q4 Results Preview: Margins of Pharma companies likely to remain under pressure in the March quarter

According to industry experts, high raw material and logistics costs will reduce EBITDA and PAT margins in the fourth quarter of FY22.

Suven Pharmaceuticals set to acquire Casper Pharma for 155 crore

Suven Pharmaceuticals Limited stated on Tuesday that it will pay  <span class='webrupee'>₹</span>155 crore in cash for Casper Pharma.

As Covid-19 ebbs, what should be your strategy for the pharma sector?

Experts point out as the fears of Covid-19 have ebbed, state-wise budgets have come down this year as temporary hospitals and other state government services related to Covid-19 are not required as of now.

Top Pharma News

markets

Stocks to buy: From Cipla to Fortis, ICICI Securities bets on these 8 firms in healthcare space

markets

markets

markets